Periprocedural acute haemodynamic decompensation during substrate-based ablation of scar-related ventricular tachycardia: a rare and unpredictable event
Jazyk angličtina Země Anglie, Velká Británie Médium print
Typ dokumentu časopisecké články
Grantová podpora
LX22NPO5104
National Institute for Research of Metabolic and Cardiovascular Diseases
European Union, NextGenerationEU
00023001
project (Ministry of Health, Czech Republic) for development of research organization
PubMed
38864730
PubMed Central
PMC11167661
DOI
10.1093/europace/euae145
PII: 7691506
Knihovny.cz E-zdroje
- Klíčová slova
- Acute haemodynamic decompensation, Catheter ablation, Mechanical circulatory support, PAINESD score, Risk assessment, Ventricular tachycardia,
- MeSH
- hemodynamika * MeSH
- hypotenze etiologie patofyziologie diagnóza MeSH
- jizva patofyziologie MeSH
- katetrizační ablace * škodlivé účinky MeSH
- komorová tachykardie * chirurgie patofyziologie etiologie diagnóza MeSH
- lidé středního věku MeSH
- lidé MeSH
- plicní edém etiologie diagnóza patofyziologie MeSH
- pooperační komplikace etiologie diagnóza MeSH
- retrospektivní studie MeSH
- rizikové faktory MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
AIMS: Patients with structural heart disease (SHD) undergoing catheter ablation (CA) for ventricular tachycardia (VT) are at considerable risk of periprocedural complications, including acute haemodynamic decompensation (AHD). The PAINESD score was proposed to predict the risk of AHD. The goal of this study was to validate the PAINESD score using the retrospective analysis of data from a large-volume heart centre. METHODS AND RESULTS: Patients who had their first radiofrequency CA for SHD-related VT between August 2006 and December 2020 were included in the study. Procedures were mainly performed under conscious sedation. Substrate mapping/ablation was performed primarily during spontaneous rhythm or right ventricular pacing. A purposely established institutional registry for complications of invasive procedures was used to collect all periprocedural complications that were subsequently adjudicated using the source medical records. Acute haemodynamic decompensation triggered by CA procedure was defined as intraprocedural or early post-procedural (<12 h) development of acute pulmonary oedema or refractory hypotension requiring urgent intervention. The study cohort consisted of 1124 patients (age, 63 ± 13 years; males, 87%; ischaemic cardiomyopathy, 67%; electrical storm, 25%; New York Heart Association Class, 2.0 ± 1.0; left ventricular ejection fraction, 34 ± 12%; diabetes mellitus, 31%; chronic obstructive pulmonary disease, 12%). Their PAINESD score was 11.4 ± 6.6 (median, 12; interquartile range, 6-17). Acute haemodynamic decompensation complicated the CA procedure in 13/1124 = 1.2% patients and was not predicted by PAINESD score with AHD rates of 0.3, 1.8, and 1.1% in subgroups by previously published PAINESD terciles (<9, 9-14, and >14). However, the PAINESD score strongly predicted mortality during the follow-up. CONCLUSION: Primarily substrate-based CA of SHD-related VT performed under conscious sedation is associated with a substantially lower rate of AHD than previously reported. The PAINESD score did not predict these events. The application of the PAINESD score to the selection of patients for pre-emptive mechanical circulatory support should be reconsidered.
1st Faculty of Medicine Institute of Physiology Charles University Prague Czechia
Institute for Clinical and Experimental Medicine Vídeňská 1958 9 Prague 140 21 Czechia
doi: 10.1093/europace/euae144 PubMed
Zobrazit více v PubMed
Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, et al. Esc guidelines for the management of V tachyarrhytmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Eur Heart J 2022;43:3997–4126. PubMed
Natale A, Zeppenfeld K, Della BP, Liu X, Sabbag A, Santangeli P, et al. Twenty-five years of catheter ablation of ventricular tachycardia: a look back and a look forward. Europace 2023;25:euad225. PubMed PMC
Conti S, Pala S, Biagioli V, Del Giorno G, Zucchetti M, Russo E, et al. Electrical storm: a clinical and electrophysiological overview. World J Cardiol 2015;7:555. PubMed PMC
Koželuhová M, Peichl P, Hlivák P, Čihák R, Wichterle D, Vančura V, et al. Spektrum idiopatických komorových tachykardií ve specializovaném centru. Interv a akutní Kardiol 2009;8:228–232.
Bennett RG, Turnbull S, Sood A, Aung M, Duncan E, Barman P, et al. Emergency out-of-hours catheter ablation for ventricular arrhythmia storm: a UK and Australian experience. Europace 2023;25:euad215. PubMed PMC
Gula LJ, Doucette S, Leong-Sit P, Tang ASL, Parkash R, Sarrazin JF, et al. Quality of life with ablation or medical therapy for ventricular arrhythmias: a substudy of VANISH. J Cardiovasc Electrophysiol 2018;29:421–434. PubMed
Zeppenfeld K, Wijnmaalen AP, Ebert M, Baldinger SH, Berruezo A, Catto V, et al. Clinical outcomes in patients with dilated cardiomyopathy and ventricular tachycardia. J Am Coll Cardiol 2022;80:1045–1056. PubMed
Santangeli P, Muser D, Zado ES, Magnani S, Khetpal S, Hutchinson MD, et al. Acute hemodynamic decompensation during catheter ablation of scar-related ventricular tachycardia: incidence, predictors, and impact on mortality. Circ Arrhythmia Electrophysiol 2015;8:68–75. PubMed
Muser D, Castro SA, Liang JJ, Santangeli P. Identifying risk and management of acute haemodynamic decompensation during catheter ablation of ventricular tachycardia. Arrhythmia Electrophysiol Rev 2018;7:282–287. PubMed PMC
Muser D, Liang JJ, Castro SA, Hayashi T, Enriquez A, Troutman GS, et al. Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergoing catheter ablation of scar-related ventricular tachycardia: a propensity-score matched analysis. Hear Rhythm 2018;15:1500–1506. PubMed
Neuzner J, Dietze T, Paliege R, Gradaus R. Effectiveness of a percutaneous left ventricular assist device in preventing acute hemodynamic decompensation during catheter ablation of ventricular tachycardia in advanced heart failure patients: a retrospective single-center analysis. J Cardiovasc Electrophysiol 2019;30:2864–2868. PubMed
Mathuria N, Wu G, Rojas-Delgado F, Shuraih M, Razavi M, Civitello A, et al. Outcomes of pre-emptive and rescue use of percutaneous left ventricular assist device in patients with structural heart disease undergoing catheter ablation of ventricular tachycardia. J Interv Card Electrophysiol 2017;48:27–34. PubMed
Kautzner J, Čihák R, Peichl P, Vančura V, Bytešník J. Catheter ablation of ventricular tachycardia following myocardial infarction using three-dimensional electroanatomical mapping. Pacing Clin Electrophysiol 2003;26:342–347. PubMed
Kahle AK, Jungen C, Alken FA, Scherschel K, Willems S, Pürerfellner H, et al. Management of ventricular tachycardia in patients with ischaemic cardiomyopathy: contemporary armamentarium. Europace 2022;24:538–551. PubMed
Hanaki Y, Komatsu Y, Nogami A, Kowase S, Kurosaki K, Sekiguchi Y, et al. Combined endo- and epicardial pace-mapping to localize ventricular tachycardia isthmus in ischaemic and non-ischaemic cardiomyopathy. Europace 2022;24:587–597. PubMed
Yamashita S, Sacher F, Mahida S, Berte B, Lim HS, Komatsu Y, et al. Image integration to guide catheter ablation in scar-related ventricular tachycardia. J Cardiovasc Electrophysiol 2016;27:699–708. PubMed
Yamashita S, Sacher F, Hooks DA, Berte B, Sellal JM, Frontera A, et al. Myocardial wall thinning predicts transmural substrate in patients with scar-related ventricular tachycardia. Hear Rhythm 2017;14:155–163. PubMed
Bunch TJ, Weiss JP, Crandall BG, Day JD, Dimarco JP, Ferguson JD, et al. Image integration using intracardiac ultrasound and 3D reconstruction for scar mapping and ablation of ventricular tachycardia. J Cardiovasc Electrophysiol 2010;21:678–684. PubMed
Engert F, Bahlke F, Erhard N, Krafft H, Popa M-A, Risse E, et al. VT ablation based on CT imaging substrate visualization: results from a large cohort of ischemic and non-ischemic cardiomyopathy patients. Clin Res Cardiol 2023. doi:10.1007/s00392-023-02321-1 PubMed DOI PMC
Esposito A, Palmisano A, Antunes S, Maccabelli G, Colantoni C, Rancoita PMV, et al. Cardiac CT with delayed enhancement in the characterization of ventricular tachycardia structural substrate: relationship between CT-segmented scar and electro-anatomic mapping. JACC Cardiovasc Imaging 2016;9:822–832. PubMed
Siontis KC, Kim HM, Dabbagh GS, Latchamsetty R, Stojanovska J, Jongnarangsin K, et al. Association of preprocedural cardiac magnetic resonance imaging with outcomes of ventricular tachycardia ablation in patients with idiopathic dilated cardiomyopathy. Hear Rhythm 2017;14:1487–1493. PubMed
Komatsu Y, Cochet H, Jadidi A, Sacher F, Shah A, Derval N, et al. Regional myocardial wall thinning at multidetector computed tomography correlates to arrhythmogenic substrate in postinfarction ventricular tachycardia: assessment of structural and electrical substrate. Circ Arrhythmia Electrophysiol 2013;6:342–350. PubMed
Kumar S, Baldinger SH, Romero J, Fujii A, Mahida SN, Tedrow UB, et al. Substrate-based ablation versus ablation guided by activation and entrainment mapping for ventricular tachycardia: a systematic review and meta-analysis. J Cardiovasc Electrophysiol 2016;27:1437–1447. PubMed
Skhirtladze K, Mora B, Moritz A, Birkenberg B, Ankersmit HJ, Dworschak M. Impaired recovery of cardiac output and mean arterial pressure after successful defibrillation in patients with low left ventricular ejection fraction. Resuscitation 2010;81:1123–1127. PubMed
Eckardt L, Doldi F, Anwar O, Gessler N, Scherschel K, Kahle A-K, et al. Major in-hospital complications after catheter ablation of cardiac arrhythmias: individual case analysis of 43 031 procedures CLINICAL RESEARCH. Europace 2023;26:1–12. PubMed PMC
Peichl P, Wichterle D, Pavlů L, ČihÁk R, Aldhoon B, Kautzner J. Complications of catheter ablation of ventricular tachycardia a single-center experience. Circ Arrhythmia Electrophysiol 2014;7:684–690. PubMed
Santangeli P, Frankel DS, Tung R, Vaseghi M, Sauer WH, Tzou WS, et al. Early mortality after catheter ablation of ventricular tachycardia in patients with structural heart disease. J Am Coll Cardiol 2017;69:2105–2115. PubMed
Martins A, Antonio PS, Pereira SC, Brito J, Silva BV, Da Silva PA, et al. Is it possible to predict mortality and recurrence of VT after ablation? PAINESD risk score applicability vs new predictors. EP Eur 2022;24:40695.
Della BP, Baratto F, Tsiachris D, Trevisi N, Vergara P, Bisceglia C, et al. Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: long-term outcome after ablation. Circulation 2013;127:1359–1368. PubMed
Kusa S, Miller MA, Whang W, Enomoto Y, Panizo JG, Iwasawa J, et al. Outcomes of ventricular tachycardia ablation using percutaneous left ventricular assist devices. Circ Arrhythmia Electrophysiol 2017;10:1–7. PubMed
Percutaneous mechanical support in catheter ablation of ventricular arrhythmias: hype or hope?